The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1299
November 17, 2008
View Complete Issue         Table of Contents 2019 
Issue 1299
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Advertisements for TNF Inhibitors
November 17, 2008 (Issue: 1299)
Some tumor necrosis factor (TNF) inhibitors are being promoted on the internet directly to the public for use in psoriasis (www.yahoo.com).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1299
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.